[Maintenance therapy in cranio-facial pain: a controlled trial with tiapride (author's transl)].
Tiapride, which belongs to the anisamide family, has an anti-dopaminergic effect, mainly on the mesolimbic system but also directly at the vascular level. A controlled trial was performed in 25 patients suffering from intractable migraine or facial vascular pain. Results were excellent in ten cases. Prescription of tiapride is therefore advised whenever usual therapy has failed.
D000328:Adult; D001549:Benzamides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005145:Face / Q000098:blood supply; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D013976:Tiapamil Hydrochloride / Q000008:administration & dosage / Q000627:therapeutic use*
D001549:Benzamides; D013976:Tiapamil Hydrochloride
Traitement de fond des algies crânio-faciales. Expérimentation du tiapride.